A Web-based Calculator Predicts Heterogeneous Frailty Trajectories
NCT05982899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 412
Last updated 2023-08-09
Summary
To explore the predictive factors of frailty trajectories and develop a web-based nomogram among gastric cancer survivors.
Conditions
Sponsors & Collaborators
-
Nanjing Medical University
lead OTHER
Eligibility
- Min Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2022-10-01
- Completion
- 2023-04-01
Countries
- China
Study Locations
More Related Trials
-
Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy
NCT06277453 ·Status: ACTIVE_NOT_RECRUITING
-
A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer
NCT07096947 ·Status: COMPLETED
-
the Optimal Surveillance Frequency for Stage II/III Gastric Cancer
NCT05465993 ·Status: COMPLETED
-
Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study
NCT01558011 ·Status: TERMINATED ·Phase: PHASE2
-
The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study
NCT02583659 ·Status: UNKNOWN
-
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
NCT02674373 ·Status: UNKNOWN
-
Plasma Metabolic Biomarkers for Gastric Cancer Diagnosis
NCT06109805 ·Status: COMPLETED
-
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
NCT03027427 ·Status: COMPLETED
-
General Tissue Response Classification System After Chemotherapy
NCT03791268 ·Status: UNKNOWN
-
Exploring the Difference Between Gastric Cardia Cancer and Non-cardia Gastric Cancer Based on Multiomics
NCT05812287 ·Status: NOT_YET_RECRUITING
-
The Effect of Immunological Heterogeneity of Tumor Microenvironment in the Prognosis of Gastric Cancer
NCT04819958 ·Status: UNKNOWN
-
Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application
NCT06335576 ·Status: NOT_YET_RECRUITING
-
Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric Cancer
NCT05140746 ·Status: RECRUITING ·Phase: NA
-
Predicting Biomarker of Gastric Cancer Chemotherapy Response
NCT03253107 ·Status: RECRUITING
-
Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric Cancer
NCT06673472 ·Status: COMPLETED
-
Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy
NCT01905969 ·Status: UNKNOWN
-
Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
NCT03632746 ·Status: UNKNOWN
-
Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer
NCT06478394 ·Status: RECRUITING
-
Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer
NCT06791148 ·Status: RECRUITING ·Phase: PHASE2
-
A Benefit Population Atlas of nICT Versus nCT for LAGC
NCT07098104 ·Status: COMPLETED
-
Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Gastric Cancer
NCT02873520 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Multi-omics-based Metabolic Typing Study of Gastric Cancer
NCT06134011 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
NCT03425058 ·Status: COMPLETED
-
A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients
NCT05442138 ·Status: UNKNOWN
-
Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer
NCT02289378 ·Status: UNKNOWN ·Phase: PHASE2